| SC 13G/A | 2017-05-08 | OppenheimerFunds, Inc. | MACROGENICS INC | 3,601,669 | 10.3% | EDGAR |
| SC 13G/A | 2017-02-14 | FMR LLC | MACROGENICS INC | 5,225,358 | 15.0% | EDGAR |
| SC 13G/A | 2017-02-14 | Point72 Asset Management, L.P. | MACROGENICS INC | 188,700 | 0.5% | EDGAR |
| SC 13G/A | 2017-02-14 | BB BIOTECH AG | MACROGENICS INC | 1,920,000 | 5.5% | EDGAR |
| SC 13G/A | 2017-01-31 | OppenheimerFunds, Inc. | MACROGENICS INC | 3,037,007 | 8.7% | EDGAR |
| SC 13G/A | 2017-01-25 | BlackRock Inc. | MACROGENICS INC | 2,483,677 | 7.1% | EDGAR |
| SC 13G | 2016-12-29 | BB BIOTECH AG | MACROGENICS INC | 1,800,000 | 5.2% | EDGAR |
| SC 13G/A | 2016-02-16 | Point72 Asset Management, L.P. | MACROGENICS INC | 2,111,876 | 6.2% | EDGAR |
| SC 13G/A | 2016-02-12 | FMR LLC | MACROGENICS INC | 3,605,231 | 10.5% | EDGAR |
| SC 13G/A | 2016-02-12 | ALTA BIOPHARMA PARTNERS III LP | MACROGENICS INC | 0 | 0.0% | EDGAR |
| SC 13G | 2016-02-04 | OppenheimerFunds, Inc. | MACROGENICS INC | 2,888,944 | 8.4% | EDGAR |
| SC 13G | 2016-01-28 | BlackRock Inc. | MACROGENICS INC | 2,087,529 | 6.1% | EDGAR |
| SC 13G/A | 2015-02-17 | Point72 Asset Management, L.P. | MACROGENICS INC | 1,538,771 | 5.5% | EDGAR |
| SC 13G/A | 2015-02-13 | FMR LLC | MACROGENICS INC | 3,212,042 | 11.6% | EDGAR |
| SC 13G/A | 2015-02-13 | TPG Group Holdings (SBS) Advisors, Inc. | MACROGENICS INC | - | 0.0% | EDGAR |
| SC 13G/A | 2015-02-13 | INTERWEST PARTNERS VIII LP | MACROGENICS INC | 1,236,219 | 4.5% | EDGAR |
| SC 13G | 2015-02-12 | ALTA BIOPHARMA PARTNERS III LP | MACROGENICS INC | 1,561,635 | 5.6% | EDGAR |
| SC 13G/A | 2015-02-05 | MPM BIOVENTURES II QP LP | MACROGENICS INC | 0 | 0.0% | EDGAR |
| SC 13G | 2015-02-05 | JOHNSON & JOHNSON | MACROGENICS INC | 1,923,077 | 6.5% | EDGAR |
| SC 13G/A | 2014-06-10 | FMR LLC | MACROGENICS INC | 3,151,149 | 11.4% | EDGAR |